Requires health plans and Medicaid to cover Alzheimer's biomarker testing.
This bill would require private health insurance plans and Medicaid to cover Alzheimer's biomarker testing. This means people with these plans would get help paying for tests that can detect Alzheimer's early. The bill also sets rules to prevent high costs or long waits for these important tests.
Right now, whether private insurance or Medicaid covers Alzheimer's biomarker testing can vary, often with high costs or long approval times. If this bill becomes law, both private insurance and Medicaid would be required to cover these tests, with rules in place to ensure fair costs and quick approval processes.
HR 9823 · 119th Congress · July 22, 2026 · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers